DS
KRRO icon

David Shaw’s Korro Bio KRRO Stock Holding History

David Shaw’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$451K Buy
+34,213
New +$425K ﹤0.01% 4231
2025
Q3 		– Sell
-24,383
Closed -$305K – 4762
2025
Q2 		$305K Buy
+24,383
New +$351K ﹤0.01% 3865
2021
Q1 		– Sell
-368
Closed -$649K – 4281
2020
Q4 		$649K Buy
+368
New +$486K ﹤0.01% 3266
2020
Q1 		– Sell
-371
Closed -$325K – 4104
2019
Q4 		$325K Buy
+371
New +$289K ﹤0.01% 3597

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

David Shaw's KRRO Position: Q2 2026 in Review

David Shaw opened a new position in Korro Bio (KRRO) in Q2 2026: 34,213 shares worth $451K. The stake represents ﹤0.01% of the portfolio and ranks #4231 among its holdings. This is a return to the name: David Shaw previously reported a position in KRRO as recently as Q2 2025.

David Shaw first reported a position in KRRO in Q4 2019 and has held it in 4 quarters since. The position peaked at $649K in Q4 2020. 106 funds tracked by Wall St. Rank hold KRRO as of Q2 2026.

  • David Shaw held 34,213 shares of Korro Bio worth $451K as of Q2 2026.
  • Korro Bio was a new David Shaw position in Q2 2026.
  • Korro Bio made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #4231 holding.
  • David Shaw first reported a position in Korro Bio in Q4 2019 and has held it in 4 quarters since.
  • David Shaw's Korro Bio position peaked at $649K in Q4 2020.
  • 106 funds tracked by Wall St. Rank held Korro Bio as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.